US 10345310
Diagnostic test for early stage cancer
granted A61KA61K31/685A61K31/727
Quick answer
US patent 10345310 (Diagnostic test for early stage cancer) held by The Board of Regents of the University of Texas System expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/685, A61K31/727, A61K9/127